Vol. 8, Issue 9, Part G (2024)

Study the levels of interleukin 9, insulin, HOMA-IR, and lipid profile in Iraqi type 2 diabetes mellitus

Author(s):

Hussein Najm Abed, Fadhil Faez Sead, Abdullah Shakir and Farqad Hasan Falih AL-Daemi

Abstract:

Diabetes mellitus DM is a sort of metabolism disorder that causes increases glucose in the blood on prolonged. various studies have found that different cytokines may have a role in the development and progression of type 2 DM. Many studies have suggested that interleukin 9 may have an etiopathological function in type 2 DM. In our study, we investigated the levels of interleukin 9 in diabetes patients and compared them to levels of the same marker in healthy controls.

A total of two hundred Iraqi volunteers (100 Type II diabetes mellitus patients and 100 healthy control individuals) were enrolled in the case-control investigation to evaluate interleukin 9, which has been measured using enzyme-linked immunoabsorbent assays.

Patients with type 2 diabetes Mellitus observed significantly decreased serum interleukin 9 levels compared to healthy controls. Type 2 Diabetes Mellitus patients with high lipid levels showed a significantly higher drop in interleukin 9 levels compared to those without. Therefore, low levels of interleukin 9 might be regarded as a possible biomarker associated with a higher risk of lipids. So, our results declare there is a relationship between the incidence of type 2 diabetes mellitus and increase in the levels of interleukin 9.

Pages: 491-494  |  269 Views  93 Downloads

How to cite this article:
Hussein Najm Abed, Fadhil Faez Sead, Abdullah Shakir and Farqad Hasan Falih AL-Daemi. Study the levels of interleukin 9, insulin, HOMA-IR, and lipid profile in Iraqi type 2 diabetes mellitus. Int. J. Adv. Biochem. Res. 2024;8(9):491-494. DOI: 10.33545/26174693.2024.v8.i9g.2198